The CAR T Case Study features a 15-year-old Hispanic female diagnosed with pre-B acute lymphoblastic leukemia in February 2023. She underwent COG high-risk four-drug induction as per AALL 1732 protocol. Our ExPeCT anti-CD19 CAR T assay offers crucial insights for Hematology/Oncology patients, monitoring CAR T-cell therapy effectiveness, assessing immune response, and guiding treatment decisions.

Please complete the form to access this resource.